Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Schizophrenia, Undifferentiated”

9 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 9 of 9 results

Testing effectiveness (Phase 2)Study completedNCT00506077
What this trial is testing

MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016)

Who this might be right for
Paranoid Schizophrenia
Merck Sharp & Dohme LLC 55
Large-scale testing (Phase 3)Study completedNCT01190267
What this trial is testing

Flexible Dose, Long-term Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05897)

Who this might be right for
Schizophrenia, ParanoidSchizophrenia, DisorganizedSchizophrenia, Undifferentiated
Organon and Co 204
Testing effectiveness (Phase 2)Study completedNCT00103727
What this trial is testing

Study Of Talnetant Versus Placebo And Risperidone In Schizophrenia

Who this might be right for
Schizophrenia
GlaxoSmithKline 282
Not applicableUnknownNCT00563017
What this trial is testing

Evaluation of Efficacy and Safety of Long-acting Risperidone Microspheres in Patients With Schizophrenia or Other Psychotic Disorders When Switching From Typical Antipsychotic (Oral/Depot) or Atypical Oral Other Than Risperidone

Who this might be right for
Schizophrenia, CatatonicSchizophrenia, DisorganizedSchizophrenia, Paranoid+2 more
Hospital Authority, Hong Kong 30
Large-scale testing (Phase 3)Study completedNCT01190254
What this trial is testing

Fixed Dose Efficacy and Safety Study of Asenapine for the Treatment of Schizophrenia in Adolescents (P05896)

Who this might be right for
Schizophrenia, ParanoidSchizophrenia, DisorganizedSchizophrenia, Undifferentiated
Organon and Co 306
Not applicableStudy completedNCT03028545
What this trial is testing

Representations and Strategies for Recovery

Who this might be right for
Schizophrenia, UndifferentiatedAnorexiaBipolar Disorders+1 more
Hôpital le Vinatier 37
Post-approval studies (Phase 4)Study completedNCT01109147
What this trial is testing

Comparison of the Effects of Aripiprazole and Risperidone on the Pattern of Brain Activation in Schizophrenic Patients

Who this might be right for
Schizophrenia, Undifferentiated Type
Qualissima 67
Testing effectiveness (Phase 2)Study completedNCT01176721
What this trial is testing

Transcutaneous Non-invasive Vagus Nerve Stimulation (t-VNS) in the Treatment of Schizophrenia

Who this might be right for
Schizophrenia
cerbomed GmbH 20
Testing effectiveness (Phase 2)Study completedNCT00482430
What this trial is testing

MK0557 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0557-027)

Who this might be right for
Paranoid SchizophreniaSchizophrenia
Merck Sharp & Dohme LLC 50